Frequent coauthors
- SCHMIDT ANJA 168
- MOELLER CARSTEN 168
- SCHWEDE WOLFGANG 105
- SCHMEES NORBERT 63
- KAUFMANN-REICHE ULRIKE 56
- BOTHE ULRICH 56
- ROTGERI ANDREA 49
- KIRKLAND THOMAS ANDREW 42
- HILLISCH ALEXANDER 28
- DROESCHER PETER 28
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The invention relates to the treatment of endometriosis using cMet inhibitors, and medication comprising cMet inhibitors for treating endometriosis.
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…
The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometri…